关闭
 
读者在线:用户名 密码
首页 期刊简介 投稿须知 期刊目录 专家风采 编委会 特邀顾问 联系我们 移动出版
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5



刊物信息

期刊名称:药物分析杂志
主管单位:中国科学技术协会
主办单位:中国药学会
承办:中国食品药品检定研究院
主编:金少鸿
地址:北京天坛西里2号
邮政编码:100050
电话:010-67012819,67058427
电子邮箱:ywfx@nifdc.org.cn
国际标准刊号:ISSN 0254-1793
国内统一刊号:CN 11-2224/R
邮发代号:2-237
 

访问统计
您是第  1 3 2 9 3 2 0 0 位浏览者
您当前的位置:首页 >> 正文

超高效液相串联质谱法测定大鼠血浆中胡麻属苷浓度

Content determination of sesamoside in rat plasma by ultra performance liquid chromatography-tandem mass spectrometry

分类号:
出版年·卷·期(页码):2016,36 (6):0-0
DOI: 10.16155/j.0254-1793.2017.01.01
-----摘要:-------------------------------------------------------------------------------------------

目的: 建立超高效液相串联质谱法快速测定大鼠体内胡麻属苷的浓度。方法: 用乙腈沉淀蛋白方法处理血浆,色谱柱为ACQUITY UPLC BEH C18 柱(50 mm×2.1 mm,1.7 μm),流动相为乙腈-0.1% 甲酸水,梯度洗脱,流速为0.4 mL·min-1;用正离子多离子反应监测(MRM)扫描,内标为芦丁。结果: 血浆中胡麻属苷的线性范围为1~250 ng·mL-1(r=0.998 6),最低定量限为0.2 ng·mL-1;胡麻属苷的日内、日间RSD 均<10%。大鼠单次灌胃胡麻属苷后,胡麻属苷在大鼠体内的t1/2 为(1.35±0.26)h,CL 为(8.62±1.25)L·h-1·kg-1,AUC0-t 为(349.57±48.5)ng·h·mL-1;大鼠舌下静注胡麻属苷后,胡麻属苷在大鼠体内的t1/2 为(1.45±0.28)h,CL 为(2.38±0.57)L·h-1·kg-1,AUC0-t 为(128.79±30.52)ng·h·mL-1,得胡麻属苷的绝对生物利用度为26.6%。结论: 该方法经方法学验证,适于大鼠血浆中胡麻属苷浓度的测定及其药代动力学研究。

-----英文摘要:---------------------------------------------------------------------------------------

Objective: To develop an ultra performance liquid chromatography-tandem mass spectrometry method for the content determination of sesamoside in rat plasma. Methods: Plasmas were precipitated with 200μL acetonitrile. An ACQUITY UPLC BEH C18(50 mm×2.1 mm,1.7 μm)column was used as the stationary phase. The mobile phase was consisted of acetonitrile and 0.1% formic acid water with gradient elution at a flow rate of 0.4 mL·min-1. The analytes were detected with positive electrospray ionization in multiple reaction monitoring(MRM)mode and rutin was used as internal standard. Results: Excellent linear calibration curve of sesamoside was obtained in the concentration range of 1-250 ng·mL-1(r=0.998 6). The lowesr limit of quantification was 0.2 ng·mL-1. t1/2 of sesamoside in rats was(1.35±0.26)h,CL of sesamoside in rats was (8.62±1.25)L·h-1·kg-1,AUC0-t of sesamoside in rats was(349.57±48.5)ng·h·mL-1 following intragastric administration of sesamoside;t1/2 of sesamoside in rats was(1.45±0.28)h,CL of sesamoside in rats was (2.38±0.57)L·h-1·kg-1,AUC0-t of sesamoside in rats was(128.79±30.52)ng·h·mL-1 following sublingual intravenous administration of sesamoside,whose absolute bioavailabilityrate was 26.6%. The intra and inter day relative standard deviations of sesamoside were all below 10%. Conclusion: The established method is proved by methodology validation that it is suitable for pharmacokinetics study of sesamoside in rats.

-----参考文献:---------------------------------------------------------------------------------------

欢迎阅读《药物分析杂志》!您是该文第 1127位读者!

药物分析杂志 © 2009
地址:北京天坛西里2号 邮政编码:100050; 电子邮件:ywfx@nicpbp.org.cn